PortugalTuberculosis profile
Population  2014 10 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.12 (0.12–0.13) 1.2 (1.1–1.3)
Mortality (HIV+TB only) 0.038 (0.023–0.057) 0.37 (0.22–0.54)
Prevalence  (includes HIV+TB) 3 (1.3–5.4) 29 (13–51)
Incidence  (includes HIV+TB) 2.6 (2.3–2.9) 25 (22–28)
Incidence (HIV+TB only) 0.37 (0.31–0.43) 3.5 (3–4.1)
         
Case detection, all forms (%) 84 (74–96)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 0.98 (0.51–1.7) 4.9 (1.6–11)
MDR-TB cases among notified pulmonary
TB cases
15 (8–25) 7 (2–15)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 1 257   71
Pulmonary, clinically diagnosed 219   11
Extrapulmonary 595   16
       
Total new and relapse 2 169    
Previously treated, excluding relapses 57    
Total cases notified 2 226    
Among 2 169 new and relapse cases:
43 (2%) cases aged under 15 years; male:female ratio: 1.7
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 822 (65%) 76 (49%) 898
Laboratory-confirmed RR-/MDR-TB cases     26
Patients started on MDR-TB treatment ***     22
TB/HIV 2014 Number (%)
TB patients with known HIV status 1 432 (64)
HIV-positive TB patients 221 (15)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (74) 2 336
Previously treated cases, excluding relapse, registered in 2013 (56) 52
HIV-positive TB cases, all types, registered in 2013 (54) 249
RR-/MDR-TB cases started on second-line treatment in 2012 (47) 19
XDR-TB cases started on second-line treatment in 2012 (50) 4
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-05-27 Data: www.who.int/tb/data